Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: cytokine and gene therapy with IL-2 and GM-CSF

Mikyšková, R., Indrová, M., Šímová, J., Jandlová, T., Bieblová, J., Jinoch, P., Bubeník, J., Vonka, V. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: cytokine and gene therapy with IL-2 and GM-CSF. International Journal of Oncology. 2004, 24(1), 161-167. ISSN 1019-6439. E-ISSN 1791-2423.